GW Pharma 's latest quarter revenues came in @ $108m (USD) and are getting a fair amount of media coverage here in the states,...... wind back the clock three years or so and - for some - it was 'all hype':
"GW Pharmaceuticals Is Terribly Overvalued
Feb. 21, 2017 11:12 AM ET About: GW Pharmaceuticals plc (GWPH), Includes: ZYNESummaryGW Pharmaceutical's Epidolex is on track to becoming Americas first FDA approved cannabis-based drug.
Despite the good news, the company's $3 billion plus enterprise value is unrealistically optimistic.
Cannabis is not a magic bullet. And the commercial flop of Sativex, GW's first cannabis-based therapy, should serve as a precaution.
When most people think about investing in Marijuana, they think about seedy OTC pot stocks trading for pennies. However, there are reputable companies in the space. These companies deal with marijuana as a medicinal plant,....
https://seekingalpha.com/article/4047826-gw-pharmaceuticals-is-terribly-overvalued
....that was then, this is now:
Q: Given the larger market, could BOT end up in three years time with a MC in the billions?
GW Pharma 's latest quarter revenues came in @ $108m (USD) and...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
0.020(6.45%) |
Mkt cap ! $519.7M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 33.5¢ | 30.5¢ | $2.848M | 8.878M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 24615 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 105525 | 2 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
33.0¢ |
Change
0.020 ( 6.73 %) |
||||
| Open | High | Low | Volume | ||
| 31.0¢ | 33.5¢ | 30.8¢ | 3931977 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| BOT (ASX) Chart |